US 7816076
Therapeutic targets in cancer
granted A61KA61K39/00
Quick answer
US patent 7816076 (Therapeutic targets in cancer) held by Sagres Discovery, Inc. expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sagres Discovery, Inc.
- Grant date
- Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K39/00